Cited by 2,824Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

Open access
Kadowaki, T.·2006·Journal of Clinical Investigation

Abstract

Adiponectin is an adipokine that is specifically and abundantly expressed in adipose tissue and directly sensitizes the body to insulin. Hypoadiponectinemia, caused by interactions of genetic factors such as SNPs in the Adiponectin gene and environmental factors causing obesity, appears to play an important causal role in insulin resistance, type 2 diabetes, and the metabolic syndrome, which are linked to obesity. The adiponectin receptors, AdipoR1 and AdipoR2, which mediate the antidiabetic metabolic actions of adiponectin, have been cloned and are downregulated in obesity-linked insulin resistance. Upregulation of adiponectin is a partial cause of the insulin-sensitizing and antidiabetic actions of thiazolidinediones. Therefore, adiponectin and adiponectin receptors represent potential versatile therapeutic targets to combat obesity-linked diseases characterized by insulin resistance. This Review describes the pathophysiology of adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci29126

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced levels of adiponectin have also been associated with metabolic syndrome, dyslipidemia, and cardiovascular disease.

    “Reduced levels of adiponectin have also been associated with metabolic syndrome, dyslipidemia, and cardiovascular disease [22].”
  • Antidiabetic, anti-inflammatory, and antihypertensive effects have all been established to occur in response to adiponectin.

    “Antidiabetic (162), anti-inflammatory (348), and antihypertensive (259) effects have all been established to occur in response to adiponectin.”

    From Cardiac remodeling in obesity (2008) · cites this paper as [162]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kadowaki, T.
Affiliations
The University of Tokyo (JP)
Corresponding author
Kadowaki, T.
Venue
Journal of Clinical Investigation
Published
2006-07-03
Volume
116
Issue
7
Pages
1784-1792
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2076310317
Cited by
2,824
References
131
Citations by year
2026: 64 · 2025: 72 · 2024: 98 · 2023: 97 · 2022: 92 · 2021: 166 · 2020: 137 · 2019: 130 · 2018: 139 · 2017: 137 · 2016: 159 · 2015: 162 · 2014: 198 · 2013: 214 · 2012: 197
FWCI
18.81
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (10NP0201)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
adiponectin, adiponectin receptors, AdipoR1, AdipoR2, insulin resistance, type 2 diabetes, metabolic syndrome, hypoadiponectinemia, obesity, adipokines, thiazolidinediones, genetic polymorphism, adipose tissue
MeSH terms
Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Receptors, Cell Surface, Polymorphism, Single Nucleotide, Metabolic Syndrome, Adiponectin, Receptors, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review